New book highlights how small biotech companies are outperforming big pharma
14 February 2022Biotech firms have developed nearly 40% more of key treatments for unmet medical needs, says a new book co-authored by Cambridge researchers.
Biotech firms have developed nearly 40% more of key treatments for unmet medical needs, says a new book co-authored by Cambridge researchers.
Meet the young biotech entrepreneur with two companies to her name and a plan to revolutionise the way we manage our health.
Meet social enterprise founder, Francesca O'Hanlon whose tech start-up is partnering with local plumbing businesses to bring clean water to communities in Uganda.
Professor Steve Jackson talks about drug discovery, serial entrepreneurship and the enterprising mindset.
The problem with being a futurist, says Richard Watson, is that change is happening a lot faster and a lot crazier these days. We talk to him about his recent work with the Entrepreneurship Centre and why thinking about a ‘preferred’ future is a good thing.
Entries are now open for the sixth Unilever Young Entrepreneurs Awards, supporting and celebrating inspirational young people from all over the world who have initiatives, products or services that tackle the planet’s biggest sustainability challenges.
What makes a city as small as Cambridge a hotbed for AI and machine learning start-ups? A critical mass of clever people obviously helps. But there’s more to Cambridge’s success than that.
Andy Neely is Cambridge’s Pro-Vice-Chancellor for Enterprise and Business Relations, a role which oversees the University’s activities in innovation, commercialisation and entrepreneurship. After six months in the role, he sees an entrepreneurial ecosystem that may appear complex at first – but a deeper examination reveals a combination of knowledge, expertise, support and infrastructure that makes Cambridge one of the most enterprising and entrepreneurial cities in the world.
Cambridge start-up Simprints, awarded $2.45 million in new grant money, targets the developing world with fingerprinting technology to help deliver healthcare to 1.1 billion people with no formal identification.
Dr Tim Minshall has been appointed as the inaugural Dr John C Taylor Professor of Innovation at the University of Cambridge, a new post that will build on the University’s strengths in science, engineering and entrepreneurship. Dr Minshall, who is currently Reader in Technology & Innovation Management in the Department of Engineering and Fellow of Churchill College, will take up his new post on 1 October.